Kala Bio (KALA) Total Non-Current Liabilities (2016 - 2025)

Kala Bio has reported Total Non-Current Liabilities for 10 years, with the latest figure at $1.1 million in Q3 2025.

• Quarterly Total Non-Current Liabilities fell 95.24% year-over-year to $1.1 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $1.1 million (down 95.24% YoY) and the FY2024 annual result came in at $26.2 million, down 34.67% from the prior year.
• Total Non-Current Liabilities slipped to $1.1 million in Q3 2025 per KALA's latest filing, from $23.2 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $105.2 million in Q3 2021 and troughed at $1.1 million in Q3 2025.
• A 5-year average of $50.8 million and a median of $39.6 million in 2023 frame the typical range for Total Non-Current Liabilities.
• The sharpest annual moves came in 2021 and 2025: Total Non-Current Liabilities climbed 5.66% in 2021, then plunged 95.24% in 2025.
• Over 5 years, Total Non-Current Liabilities stood at $85.2 million in 2021, then plunged by 50.52% to $42.2 million in 2022, then fell by 4.89% to $40.1 million in 2023, then plunged by 34.67% to $26.2 million in 2024, then tumbled by 95.75% to $1.1 million in 2025.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $1.1 million, $23.2 million, and $19.6 million for Q3 2025, Q2 2025, and Q1 2025 respectively.